![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BROWER PIVEN ANNOUNCES CLASS ACTION LAWSUIT AGAINST PAR PHARMACEUTICAL COMPANIES, INC.
BROWER PIVEN ANNOUNCES CLASS ACTION LAWSUIT AGAINST PAR PHARMACEUTICAL COMPANIES, INC.
July 25, 2006
The law firm of Brower Piven, a professional association, announced that a securities class action was commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of Par Pharmaceutical Companies, Inc. between April 29, 2004 and July 5, 2006, inclusive (the "Class Period"). Yahoo Finance (http://biz.yahoo.com/iw/060721/0146602.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct